New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. (Q46129148)
Jump to navigation
Jump to search
scientific article published on 5 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. |
scientific article published on 5 February 2009 |
Statements
1 reference
New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. (English)
1 reference
Young-Bae Park
1 reference
Choon-Soo Lee
1 reference
Yoo-Wook Kwon
1 reference
Han-Mo Yang
1 reference
Sung-Hwan Kim
1 reference
Tae-Youn Kim
1 reference
Jin Hur
1 reference
Kyung-Woo Park
1 reference
Hyun-Jai Cho
1 reference
Hyun-Jae Kang
1 reference
Hyo-Soo Kim
1 reference
5 February 2009
1 reference
29
1 reference
472-479
1 reference
4
1 reference
Identifiers
1 reference
1 reference